Wanbury Tanuku site clears TGA quality inspection by Australia

Regulatory Product ApprovalBusiness Updates View source PDF Explain this filing

WANBURY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.6%Reaction day

₹266.00

prior close

₹263.25

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.4%-1.1% vs market

Pharmaceuticals peers, median of 164sector-0.6%-2.0% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 2.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.3

10m

+0.7

15m

+0.9

30m

+0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.6-1.4-1.1-0.6-2.0

Next day

-3.5-2.5-1.0-1.3-2.2

+3.7+0.4+3.3-0.1+3.8

+0.4+2.2-1.7+0.4+0.1

+2.2+2.7-0.5+0.1+2.2

+0.2+3.9-3.6+0.0+0.2

-0.8+5.2-5.9+0.4-1.1

15d

+7.4+6.5+0.9+3.6+3.7

+12.8+6.9+5.9+4.2+8.6

-7.1+9.1-16.3+4.9-12.0

-9.5+11.6-21.1+8.7-18.2

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Wanbury's API manufacturing site at Tanuku, Andhra Pradesh has successfully completed a quality inspection by Australia's drug regulator TGA. Once the GMP certificate is received, the company will be able to ship 3 additional APIs. The Patalganga site also received a GMP certificate from Korean FDA for its April 2026 inspection.

Likely market impact

Positive for exports. Enables shipment of 3 additional APIs to Australia, supporting revenue growth and strengthening regulatory compliance.